Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action.

Journal of medicinal chemistry ·Vol. 13 ·No. 6 ·1970-11-00 ·Pages 1117-24

French FA, Blanz EJ, DoAmaral JR, French DA

Abstract

暂无摘要

MeSH Terms

Animals Carcinoma/drug therapy Cell-Free System Chemical Phenomena Chemistry DNA/biosynthesis Isoquinolines Leukemia L1210/drug therapy Leukemia, Myeloid/drug therapy Lymphoma/drug therapy Mice Neoplasms, Experimental/drug therapy Pyridines Sarcoma, Experimental/drug therapy Thiosemicarbazones/chemical synthesis,therapeutic use

Chemicals

Isoquinolines Pyridines Thiosemicarbazones DNA

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

French F A

Blanz E J

DoAmaral J R

French D A

Article Info

Journal

Journal of medicinal chemistry

Abbr.

J Med Chem

ISSN

0022-2623

DOI

10.1021/jm00300a024

Published

1970-11-00

Pages

1117-24

Language

English

Region

United States

NLM ID

9716531

Subset

External Links

PubMed source DOI: 10.1021/jm00300a024 View journal details

Analysis Services

Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action.

Contact

WeChat Official Account